Regulatory News: TheraVet (Paris:ALVET) (Brussels:ALVET) (ISIN: BE0974387194 ticker: ALVET), a pioneering biotechnology company specialising in the management of osteoarticular diseases in pets
Simon Wheeler is to be co-opted as an independent director and will chair TheraVet’s Board of Directors Nesya Goris and Christian Schirvel will also join the board as independent director and.
Simon Wheeler is to be co-opted as an independent director and will chair TheraVet's Board of Directors Nesya Goris and Christian Schirvel will also join the board as independent director and independent